National Health (Pharmaceutical Benefits) Amendment (Active Ingredient Prescribing) Regulations 2020
I, General the Honourable David Hurley AC DSC (Retd), Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulations.
Dated 20 August 2020
David Hurley
Governor‑General
By His Excellency’s Command
Greg Hunt
Minister for Health
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
National Health (Pharmaceutical Benefits) Regulations 2017
This instrument is the National Health (Pharmaceutical Benefits) Amendment (Active Ingredient Prescribing) Regulations 2020.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | The day after this instrument is registered. | 26 August 2020 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
National Health (Pharmaceutical Benefits) Regulations 2017
1 Subsection 102(1)
Omit “1 November 2020”, substitute “1 February 2021”.